Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of acute stroke: a misconception.

Literature DB >> 19714323

Treatment of acute stroke: a misconception.

Rüdiger von Kummer.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2009 PMID： 19714323 DOI： 10.1007/s00234-009-0585-9

Source DB: PubMed Journal: Neuroradiology ISSN： 0028-3940 Impact factor: 2.804

× No keyword cloud information.

15 in total

1. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors: W M Clark; S Wissman; G W Albers; J H Jhamandas; K P Madden; S Hamilton
Journal: JAMA Date: 1999-12-01 Impact factor: 56.272

2. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction.

Authors: M FISHER; R D ADAMS
Journal: J Neuropathol Exp Neurol Date: 1951-01 Impact factor: 3.685

3. Changing directions in acute stroke diagnostics : good-bye "mismatch"?

Authors: Rüdiger von Kummer
Journal: Klin Neuroradiol Date: 2009-06

4. Acute stroke: usefulness of early CT findings before thrombolytic therapy.

Authors: R von Kummer; K L Allen; R Holle; L Bozzao; S Bastianello; C Manelfe; E Bluhmki; P Ringleb; D H Meier; W Hacke
Journal: Radiology Date: 1997-11 Impact factor: 11.105

5. The evolution of surgery for the treatment and prevention of stroke. The Willis Lecture.

Authors: J E Thompson
Journal: Stroke Date: 1996-08 Impact factor: 7.914

6. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.

Authors: Maher Saqqur; Ken Uchino; Andrew M Demchuk; Carlos A Molina; Zsolt Garami; Sergio Calleja; Naveed Akhtar; Finton O Orouk; Abdul Salam; Ashfaq Shuaib; Andrei V Alexandrov
Journal: Stroke Date: 2007-02-08 Impact factor: 7.914

7. Tissue plasminogen activator for acute ischemic stroke.

Authors:
Journal: N Engl J Med Date: 1995-12-14 Impact factor: 91.245

8. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors: Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal: N Engl J Med Date: 2008-09-25 Impact factor: 91.245

9. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors: W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal: Lancet Date: 1998-10-17 Impact factor: 79.321

10. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors: Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal: Lancet Date: 2004-03-06 Impact factor: 79.321

3 in total